Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Allopregnanolone and Dynamic GABA-A Receptor Plasticity in Selective Serotonin Reuptake Inhibitor Responsive Premenstrual Dysphoric Disorder

NCT06704594 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.

NCT NCT06704594
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06704594 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Allopregnanolone and Dynamic GABA-A Receptor Plasticity in Selective Serotonin Reuptake Inhibitor Responsive Premenstrual Dysphoric Disorder
Lead sponsor
Johns Hopkins University
Phase
Phase 4
Overall status
Recruiting
Start date
May 14, 2025
Completion date
July 1, 2029
Enrollment
288 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

premenstrual dysphoric disorder (pmdd)